Cited by: 107 1 Like researcher6076 April 28, 2026, 5:15am #3 FWIW, I do not think FOXO4-DRI has been used in ANY human trials, not Phase 1, not Phase 2, not observational cohorts
Co-administration of mesna, which could influence distribution by ion-pairing, did not alter the pharmacokinetics
Cycle Length Typical protocol runs 412 weeks depending on the injury and response
Commonly Reported Effects The most frequently mentioned side effect is next-morning fatigue or grogginess, typically reported when doses exceed individual tolerance or timing is off
Community research planning today is mostly subcutaneous in the 100-300 mcg range
Important safety statement: This program is not intended to diagnose, treat, cure, or prevent any disease